AZTA
Price
$52.63
Change
-$0.37 (-0.70%)
Updated
Jan 17 closing price
Capitalization
3.36B
24 days until earnings call
XYLO
Price
$4.73
Change
+$0.39 (+8.99%)
Updated
Jan 17 closing price
Capitalization
5.21M
Ad is loading...

AZTA vs XYLO

Header iconAZTA vs XYLO Comparison
Open Charts AZTA vs XYLOBanner chart's image
Azenta
Price$52.63
Change-$0.37 (-0.70%)
Volume$372.1K
Capitalization3.36B
Xylo Technologies
Price$4.73
Change+$0.39 (+8.99%)
Volume$7.14K
Capitalization5.21M
AZTA vs XYLO Comparison Chart
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XYLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. XYLO commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and XYLO is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (AZTA: $52.63 vs. XYLO: $4.73)
Brand notoriety: AZTA and XYLO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 42% vs. XYLO: 41%
Market capitalization -- AZTA: $3.36B vs. XYLO: $5.21M
AZTA [@Medical Specialties] is valued at $3.36B. XYLO’s [@Medical Specialties] market capitalization is $5.21M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileXYLO’s FA Score has 1 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • XYLO’s FA Score: 1 green, 4 red.
According to our system of comparison, XYLO is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 2 TA indicator(s) are bullish while XYLO’s TA Score has 4 bullish TA indicator(s).

  • AZTA’s TA Score: 2 bullish, 3 bearish.
  • XYLO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, XYLO is a better buy in the short-term than AZTA.

Price Growth

AZTA (@Medical Specialties) experienced а +1.80% price change this week, while XYLO (@Medical Specialties) price change was +15.93% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

AZTA is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($3.36B) has a higher market cap than XYLO($5.21M). XYLO YTD gains are higher at: 30.663 vs. AZTA (5.260). AZTA has higher annual earnings (EBITDA): 57.5M vs. XYLO (-7.88M). AZTA has more cash in the bank: 984M vs. XYLO (27.3M). XYLO has less debt than AZTA: XYLO (1.62M) vs AZTA (66.5M). AZTA has higher revenues than XYLO: AZTA (641M) vs XYLO (10.1M).
AZTAXYLOAZTA / XYLO
Capitalization3.36B5.21M64,530%
EBITDA57.5M-7.88M-730%
Gain YTD5.26030.66317%
P/E RatioN/A2.68-
Revenue641M10.1M6,347%
Total Cash984M27.3M3,604%
Total Debt66.5M1.62M4,115%
FUNDAMENTALS RATINGS
AZTA vs XYLO: Fundamental Ratings
AZTA
XYLO
OUTLOOK RATING
1..100
2025
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
9297
PRICE GROWTH RATING
1..100
4442
P/E GROWTH RATING
1..100
6154
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XYLO's Valuation (1) in the Medical Specialties industry is significantly better than the same rating for AZTA (71) in the Electronic Production Equipment industry. This means that XYLO’s stock grew significantly faster than AZTA’s over the last 12 months.

AZTA's Profit vs Risk Rating (83) in the Electronic Production Equipment industry is in the same range as XYLO (100) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to XYLO’s over the last 12 months.

AZTA's SMR Rating (92) in the Electronic Production Equipment industry is in the same range as XYLO (97) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to XYLO’s over the last 12 months.

XYLO's Price Growth Rating (42) in the Medical Specialties industry is in the same range as AZTA (44) in the Electronic Production Equipment industry. This means that XYLO’s stock grew similarly to AZTA’s over the last 12 months.

XYLO's P/E Growth Rating (54) in the Medical Specialties industry is in the same range as AZTA (61) in the Electronic Production Equipment industry. This means that XYLO’s stock grew similarly to AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTAXYLO
RSI
ODDS (%)
Bearish Trend 11 days ago
83%
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
73%
Bearish Trend 11 days ago
88%
Momentum
ODDS (%)
N/A
Bullish Trend 11 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
72%
Bullish Trend 11 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 11 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
72%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 20 days ago
84%
Bearish Trend 19 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
Bullish Trend 11 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XYLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WYNN84.672.17
+2.63%
Wynn Resorts Limited
NAMS23.550.13
+0.56%
NewAmsterdam Pharma Company NV
ABUS3.20-0.02
-0.62%
Arbutus Biopharma Corp
KLXE6.65-0.06
-0.89%
KLX Energy Services Holdings
MGRX2.61-0.07
-2.61%
Mangoceuticals Inc

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with CRL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
-0.70%
CRL - AZTA
54%
Loosely correlated
-1.39%
BLFS - AZTA
48%
Loosely correlated
-1.17%
IQV - AZTA
47%
Loosely correlated
-0.15%
A - AZTA
44%
Loosely correlated
+1.82%
RVTY - AZTA
44%
Loosely correlated
-0.90%
More

XYLO and

Correlation & Price change

A.I.dvisor tells us that XYLO and LH have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XYLO and LH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XYLO
1D Price
Change %
XYLO100%
+8.99%
LH - XYLO
26%
Poorly correlated
-0.09%
EXAS - XYLO
23%
Poorly correlated
+2.58%
VVOS - XYLO
23%
Poorly correlated
-3.53%
WAT - XYLO
23%
Poorly correlated
-0.35%
AZTA - XYLO
23%
Poorly correlated
-0.70%
More